Stem Cell-Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future...

Area of Science:

• Cardiovascular regenerative medicine
• Stem cell biology
• Genomic medicine

Background:

• Cardiovascular diseases (CVDs) are a leading cause of death globally.
• The heart possesses limited intrinsic regenerative capacity.
• Human-induced pluripotent stem cells (hiPSCs) provide a scalable, patient-specific platform for cardiac research and therapy.

Purpose of the Study:

• To review recent advancements in hiPSC technology for cardiovascular applications.
• To highlight progress in differentiating hiPSCs into specialized cardiac cell types.
• To discuss emerging therapeutic delivery strategies and ongoing clinical trials.

Main Methods:

• Review of recent scientific literature on hiPSC technology and cardiovascular disease.
• Analysis of studies on hiPSC differentiation protocols, including signaling pathways and transcription factors.
• Examination of research on cell delivery methods (e.g., bioengineered patches, hydrogels) and clinical trial data.

Main Results:

• Patient-specific hiPSC models are being developed for inherited arrhythmias and cardiomyopathies.
• Significant progress has been made in directing hiPSC differentiation into cardiomyocytes, pacemaker cells, and Purkinje fibers.
• Emerging strategies for cell delivery and overcoming challenges in cell maturation and integration are discussed.

Conclusions:

• hiPSCs hold dual potential as critical research tools and therapeutic agents for cardiovascular diseases.
• Ongoing clinical trials are evaluating the safety of hiPSC-based treatments for heart failure and conduction disorders.
• Further research is needed to optimize cell maturation and functional integration for clinical success.